4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses
- PMID: 10528187
4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses
Abstract
4-1BB (CD137) is a costimulatory molecule expressed on activated T cells and interacts with 4-1BB ligand (4-1BBL) on APCs. To investigate the role of 4-1BB costimulation for the development of primary immune responses, 4-1BBL-deficient (4-1BBL-/-) mice were infected with lymphocytic choriomeningitis virus (LCMV). 4-1BBL-/- mice were able to generate CTL and eliminate acute LCMV infection with normal kinetics, but CD8 T cell expansion was 2- to 3-fold lower than in wild-type (+/+) mice. In the same mice, virus-specific CD4 Th and B cell responses were minimally affected, indicating that 4-1BB costimulation preferentially affects CD8 T cell responses. This result contrasts with our earlier work with CD40L-deficient (CD40L-/-) mice, in which the CD8 T cell response was unaffected and the CD4 T cell response was markedly impaired. When both 4-1BBL- and B7-dependent signals were absent, CD8 T cell expansion was further reduced, resulting in lower CTL activity and impairing their ability to clear LCMV. Altogether, these results indicate that T cells have distinct costimulatory requirements: optimal CD8 responses require 4-1BBL-dependent interactions, whereas CD4 responses are minimally affected by 4-1BB costimulation, but require CD40-CD40L and B7-dependent interactions.
Similar articles
-
Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.J Immunol. 1999 Nov 1;163(9):4833-41. J Immunol. 1999. PMID: 10528184
-
CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses.J Immunol. 1999 Sep 15;163(6):3194-201. J Immunol. 1999. PMID: 10477587
-
Costimulation of CD28- T lymphocytes by 4-1BB ligand.J Immunol. 1997 Jan 15;158(2):551-9. J Immunol. 1997. PMID: 8992967
-
Role of 4-1BB:4-1BB ligand in cancer immunotherapy.Cancer Gene Ther. 2004 Mar;11(3):215-26. doi: 10.1038/sj.cgt.7700670. Cancer Gene Ther. 2004. PMID: 14671675 Review.
-
Role of 4-1BB in immune responses.Semin Immunol. 1998 Dec;10(6):481-9. doi: 10.1006/smim.1998.0157. Semin Immunol. 1998. PMID: 9826581 Review.
Cited by
-
Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.ISRN Oncol. 2013 Jun 11;2013:371854. doi: 10.1155/2013/371854. Print 2013. ISRN Oncol. 2013. PMID: 23840967 Free PMC article.
-
4-1BB immunotherapy: advances and hurdles.Exp Mol Med. 2024 Feb;56(1):32-39. doi: 10.1038/s12276-023-01136-4. Epub 2024 Jan 4. Exp Mol Med. 2024. PMID: 38172595 Free PMC article. Review.
-
A ceramide analogue stimulates dendritic cells to promote T cell responses upon virus infections.J Immunol. 2015 May 1;194(9):4339-49. doi: 10.4049/jimmunol.1402672. Epub 2015 Mar 25. J Immunol. 2015. PMID: 25810392 Free PMC article.
-
Immunotherapy targeting 4-1BB and its ligand.Int J Hematol. 2006 Jan;83(1):23-8. doi: 10.1532/IJH97.05125. Int J Hematol. 2006. PMID: 16443548
-
Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication.Mol Ther. 2010 Feb;18(2):413-20. doi: 10.1038/mt.2009.210. Epub 2009 Sep 22. Mol Ther. 2010. PMID: 19773745 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous